WOC Pharma and Healthcare Fund
Ticker: mf13352
Decent
68/100
☆ Add to Watchlist
More Options
S
SBI FMP-81-1157D
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
U
Union Focused Fund
The Union Focused Fund shows potential for growth with a decent profitability profile, but caution is advised due to valuation concerns and execution risks.
View details
P
PGIM India Multi Cap Fund
The PGIM India Multi Cap Fund shows decent potential with a balanced approach to growth and profitability, though some risks remain.
View details
E
Edelweiss Consumption Fund
The Edelweiss Consumption Fund shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
E
Edelweiss ELSS Tax saver Fund
The Edelweiss ELSS Tax Saver Fund shows decent potential with consistent growth and profitability metrics, though some execution risks remain.
View details
N
Nippon India Nifty AAA PSU Bond Plus SDL - Sep 2026 Maturity 50:50 Index Fund
The fund offers stability and low risk but lacks significant growth potential, making it suitable for conservative investors.
View details
I
ITI ELSS Tax Saver Fund
The fund shows potential for moderate growth, but investors should be cautious of execution risks and market volatility.
View details
I
Invesco India - Invesco Global Consumer Trends FoF
The fund shows potential in a growing sector but faces challenges in profitability and valuation. Caution is advised.
View details
S
SBI FMP-64-1169D
The stock presents several risks with limited growth potential and inconsistent financial performance, making it a risky investment at this time.
View details
B
Bandhan CRISIL IBX Gilt April 2026 Index Fund
The Bandhan CRISIL IBX Gilt April 2026 Index Fund offers a decent investment option for conservative investors seeking stability, but growth potential is limited.
View details
B
Bank of India Large & Mid Cap Fund
The Bank of India Large & Mid Cap Fund presents a mixed outlook with several risks that could affect performance. Caution is advised for potential investors.
View details
A
Aditya Birla SL Retirement Fund-30
The fund shows potential but is hindered by several risks and inconsistent performance metrics.
View details
K
Kotak Nifty AAA Bond Financial Services Mar 2028 Index Fund
The fund exhibits several weaknesses in growth and profitability, making it a risky investment.
View details
W
WOC ELSS Tax Saver Fund
The WOC ELSS Tax Saver Fund shows decent potential with a solid growth trajectory and profitability metrics, but some risks and valuation concerns should be monitored.
View details
N
Nippon India Nifty G-Sec Sep 2027 Maturity Index Fund
The fund offers stable returns with low risk, suitable for conservative investors seeking fixed income exposure.
View details
I
Invesco India - Invesco EQQQ NASDAQ-100 ETF FoF
The Invesco EQQQ NASDAQ-100 ETF FoF presents a decent investment opportunity with exposure to high-growth sectors, though caution is advised due to valuation concerns and market volatility.
View details
Business Overview
The WOC Pharma and Healthcare Fund is a specialized investment vehicle designed for investors looking to capitalize on the growth potential of India's booming pharmaceutical and healthcare sectors. This fund is ideal for those seeking long-term capital appreciation while supporting the advancement of healthcare solutions in the country. With a focus on innovative companies and emerging trends, it plays a crucial role in enhancing access to quality healthcare.
- Focuses on India's pharmaceutical and healthcare sectors
- Ideal for long-term investors
- Supports innovative healthcare solutions
- Aims for capital appreciation
- Contributes to improving healthcare access in India
Opportunity vs Risk
Opportunities
- Growing healthcare sector in India
- Potential for high returns
- Government support for pharma
- Innovative drug development
- Rising demand for healthcare services
Risks ⚠️
- Regulatory changes impact operations
- High competition in pharma
- Market volatility risk
- Dependence on few key products
- Global economic downturn effects
📊 Stock Investment Checklist (100 Points)
WOC Pharma and Healthcare Fund • Updated: 2025-10-01 22:03:12
-
10BusinessHighPharmaceuticals and healthcare are future-ready sectors with a growing demand.
-
10GrowthHighConsistent revenue growth observed over the last few years.
-
10ProfitabilityHighROE and ROCE are above industry average, but OCF needs improvement.
-
8ValuationHighP/E and P/B ratios are slightly above peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios are concerning.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth catalysts are present, but execution risks remain high.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
WOC Pharma and Healthcare Fund shows potential for growth in a robust sector, but faces challenges in execution and valuation.